Sign in
CompletedNo phase

Quality of Life Evaluation After Cataract Surgery Using 4 Types of Intraocular Lens Implant Combinations

Key facts

Who runs it
Centre Hospitalier Régional Metz-Thionville
Where
France2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
200 people enrolled
Started
30 Jan 2023
Ended
21 May 2025
Type of study
Interventional, 4 groups
Treatments tested
  • Zeiss CT Asphina / Zeiss CT Asphina
  • Zeiss AT Lara/ Zeiss AT Lisa Tri
  • Zeiss CT Asphina/ Zeiss AT Lara
  • Zeiss AT Lara / Zeiss AT Lara
Record updated
28 May 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (31)Hide the full registry criteria

Who can take part

  • Patient suffering from bilateral cataract and undergoing cataract surgery
  • Patient with preoperative visual acuity ≤ 8/10th Monoyer (≥+ 0.1 logMar) in each eye
  • Patient with nuclear color (NC), cortical (C) or posterior capsule opacity (P) cataract of normal to severe density in the Lens Opacities Classification System III (LOCSIII)
  • Patient with cortical cataracts classified C1 to C5
  • Patient with cataracts classified as nuclear opalescence (NO)1 to NO4 and nuclear color (NC)1 to NC4
  • Patient with posterior capsule opacity cataracts classified as grade 5 (P1-P5)
  • Patient affiliated to a social security scheme
  • Patient having given written consent

Who cannot take part

  • Patient with a history (ATCD) of refractive surgery
  • Patient with ATCD intraocular surgery
  • Patient with progressive or old ocular inflammatory disease
  • Patient with pseudoexfoliative syndrome
  • Patient with age-related macular degeneration (AMD)
  • Patient with biometrics ≤ 17 Diopters (D) and ≥ 28D
  • Patient with ATCD strabismus
  • Patient with amblyopia
  • Patient with monophthalmos
  • Patient with glaucoma
  • Patient with diabetic retinopathy or maculopathy
  • Patient presenting with a very dense nuclear cataract (Stage NO5-6, NC5-6 on the LOCSIII classification), sources of preoperative complication
  • Patient with keratoconus
  • Patient with pigment dispersion
  • Patient with traumatic cataract
  • Patient with astigmatism conforming to the rule > 1.5 Diopters (D) or inverse to the rule > 1 Diopter (D)
  • Patient with abnormal ocular morphology
  • Patient with abnormal keratometry
  • Insulin-dependent diabetics and/or diabetics with retinal complications
  • Pregnant or breastfeeding women
  • Patient under legal protection (guardianship, curators, safeguard of justice)
  • Person deprived of liberty
  • Patient wishing to see near or far exclusively

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is multicenter, prospective, comparative and randomized study focusing on the evolution of the quality of Life and Uncorrected Binocular Visual Acuity (UBVA) evaluation at 3 months after cataract surgery in patients who underwent 4 different types of intraocular lens Implant (IOL) combinations.

The 4 groups in the trial

  • Zeiss CT Asphina / Zeiss CT AsphinaTreatment being tested

    Monovision with refractive target of -1.50 Diopters (D) on the dominated eye

  • Zeiss AT Lara/ Zeiss AT Lisa TriTreatment being tested

    Zeiss AT Lara (dominant eye) / Zeiss AT Lisa Tri (non-dominant eye)

  • Zeiss CT Asphina/ Zeiss AT LaraTreatment being tested

    Zeiss CT Asphina/ Zeiss AT Lara (non-dominant eye)

  • Zeiss AT Lara / Zeiss AT LaraTreatment being tested

    Micro-monovision with refractive target of -0.75 Diopters (D) on the non-dominant eye

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Quality of Life and Uncorrected Binocular Visual Acuity (UBVA) Evaluation in Patients Undergoing Cataract Surgery Using 4 Different Types of Lens Implant Combinations: a Multicenter, Prospective, Comparative and Randomized Study
Record updated
28 May 2025